Sep 16, 2026 · 39 min · 14 segments
Synopsis: What does it take to turn a once-fringe scientific idea into a new approach to drug discovery—and build a biotech company around it for the long haul? In this episode of Biotech 2050, host…
Nello MainolfiGuest
Rahul ChaturvediHost
Lots of questions, particularly around, let's say, culture and team building.

As you think about going from when you were working with Atlas, effectively a science project, to now creating a company, to now having a significant R&D organization, how has that informed how you think about culture and the types of people that you hire as you've made that shift from early stage now to having multiple programs in the clinic?

This is like the most important aspect of my job, I think, and actually is the one I spend probably more time on and the one I'm most paranoid about, which is I think the success of biotech companies have nothing to do with how smart people are, but have all to do with the culture that they build in their companies, because there is to smart people everywhere, especially in this region of the world.

And so you have to build a differentiated culture to do things that others are not doing.

And my philosophy is, as a CEO, you have to let people believe that they can do things that have never been done before.

And in fact, we've done so many things at Chimera that have never been done before by people that have never done that before.

And I have so many people tell me, you know, I've been in big companies, small companies, but I've never done what we're doing here.

And my mission is that while the culture will evolve and has evolved, The core things will never change, and I always say that if they change, I fail, then I should leave.

The things that should never change is that you need to be able to be transparent, you need to be able to be always data-driven, you need to be able to give and receive feedback, you need to be able to be challenging each other, and that the success of the company is put above the individual success.

That is like in a nutshell, some of the things that for me are non-negotiable.

So as you continue to build and you hire people, it's not a natural thing to go there, especially as you grow and you hire people from larger organization.

And I, when I see different behavior, I call it up, whether it's in a one-on-one or in a big meetings.

And in those situations, when you do have to call it out in whatever setting, have you found that most folks are able to course correct or that fundamentally it's not going to work out?

I'm a big believer that if you're passionate about discovering and developing drugs and you have a curious approach to science, you can do anything.

I think people that are not able to make sometimes their switch is more people that have lost the curiosity.

Lots of questions, particularly around, let's say, culture and team building.

As you think about going from when you were working with Atlas, effectively a science project, to now creating a company, to now having a significant R&D organization, how has that informed how you think about culture and the types of people that you hire as you've made that shift from early stage now to having multiple programs in the clinic?

This is like the most important aspect of my job, I think, and actually is the one I spend probably more time on and the one I'm most paranoid about, which is I think the success of biotech companies have nothing to do with how smart people are, but have all to do with the culture that they build in their companies, because there is to smart people everywhere, especially in this region of the world.

And so you have to build a differentiated culture to do things that others are not doing.

And my philosophy is, as a CEO, you have to let people believe that they can do things that have never been done before.

And in fact, we've done so many things at Chimera that have never been done before by people that have never done that before.

And I have so many people tell me, you know, I've been in big companies, small companies, but I've never done what we're doing here.

And my mission is that while the culture will evolve and has evolved, The core things will never change, and I always say that if they change, I fail, then I should leave.

The things that should never change is that you need to be able to be transparent, you need to be able to be always data-driven, you need to be able to give and receive feedback, you need to be able to be challenging each other, and that the success of the company is put above the individual success.

That is like in a nutshell, some of the things that for me are non-negotiable.

So as you continue to build and you hire people, it's not a natural thing to go there, especially as you grow and you hire people from larger organization.

And I, when I see different behavior, I call it up, whether it's in a one-on-one or in a big meetings.

And in those situations, when you do have to call it out in whatever setting, have you found that most folks are able to course correct or that fundamentally it's not going to work out?

I'm a big believer that if you're passionate about discovering and developing drugs and you have a curious approach to science, you can do anything.

I think people that are not able to make sometimes their switch is more people that have lost the curiosity.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.